Highlander Capital Management, LLC Voyager Therapeutics, Inc. Transaction History

Highlander Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $17,941 - $31,119	-1,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$19.18 - $27.88 $19,180 - $27,880	-1,000 Reduced 47.62%	1,100 $30,000
Q1 2019 May 15, 2019	BUY	$8.0 - $19.66 $16,800 - $41,286	2,100 New	2,100 $40,000
Q1 2018 May 16, 2018	SELL	$16.16 - $31.31 $21,412 - $41,485	-1,325 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$12.26 - $25.88 $16,244 - $34,291	1,325	1,325 $22,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $220M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.